N4 Pharma (N4P)

Sector:

Pharma and Biotech

Index:

FTSE AIM All-Share

0.48p
   
  • Change Today:
    -0.017p
  • 52 Week High: 0.53
  • 52 Week Low: 0.45
  • Currency: UK Pounds
  • Shares Issued: 832.28m
  • Volume: 0
  • Market Cap: £4.02m

Latest Deals

No deals were found in the last 365 days.

Largest Deals (365 days)

No deals were found in the last 365 days.

Director Shareholdings

Notifier Holding Value*
Nigel Theobald 12,389,919 £59,885
Luke Cairns 142,660 £690

Major Shareholders

Notifier** Holding Value*
TRACARTA LIMITED 150,000,000 £725,000
Northern Standard Limited 150,000,000 £725,000
Mathenz Marc Kay 74,000,000 £357,666
Patrick Byrne 43,162,500 £208,619
David Farrier 28,000,000 £135,333
Peel Hunt LLP 7,436,152 £35,941
MYLES MCNULTY 4,000,000 £19,333
Lynchwood Nominees Limited 690,800 £3,339
Barclays Stockbrokers Limited 447,800 £2,164
LR Nominees Limited 311,600 £1,506

* Value is calculated by using the current share price multiplied by the amount held.
** Major Shareholders are individuals or institutions that own more than 3% of the company’s shares and have been reported in the annual accounts.

Note 1: Prices and trades are provided by Digital Look Corporate Solutions and are delayed by at least 15 minutes.

 

N4 Pharma Market Data

Currency UK Pounds
Share Price 0.48p
Change Today -0.017p
% Change -3.33 %
52 Week High 0.53
52 Week Low 0.45
Volume 0
Shares Issued 832.28m
Market Cap £4.02m

N4 Pharma Star Ratings

Compare performance with the sector and the market.
more star ratings
Key: vs Market vs Sector
Value
55.81% below the market average55.81% below the market average55.81% below the market average55.81% below the market average55.81% below the market average
70.73% below the sector average70.73% below the sector average70.73% below the sector average70.73% below the sector average70.73% below the sector average
Value
55.81% below the market average55.81% below the market average55.81% below the market average55.81% below the market average55.81% below the market average
70.73% below the sector average70.73% below the sector average70.73% below the sector average70.73% below the sector average70.73% below the sector average
Income Not Available
Growth
25.67% above the market average25.67% above the market average25.67% above the market average25.67% above the market average25.67% above the market average
17.24% above the sector average17.24% above the sector average17.24% above the sector average17.24% above the sector average17.24% above the sector average

N4 Pharma Dividends

No dividends found

Trades for --2026

Time Volume / Share Price
0 @ 0.000p

N4 Pharma Key Personnel

CEO Nigel Theobald

Top of Page